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Summary 
The HIV-1 matrix (MA) protei n contains two subcellular 
localization signals with opposing effects. A myristoy- 
lated N-terminus governs particle assembly at the 
plasma membrane, and a nucleophilic motif facilitates 
import of the viral preintegration complex into the nu- 
cleus of nondividing cells. Here, we show that myris- 
toylation acts as the MA dominant targeting signal in 
HIV-1 producer cells. During virus assembly, a subset 
of MA is phosphorylated on the C-terminal tyrosine by 
a virion-associated cellular protein kinase. Tyrosine- 
phosphorylated MA is then preferentially transported 
to the nucleus of target cells. An MA tyrosine mutant 
virus grows normally in dividing cells, but is blocked 
for nuclear import in terminally differentiated macro- 
phages. MA tyrosine phosphorylation thus reveals the 
karyophilic properties of this protein within the HIV-1 
preintegration complex, thereby playing a critical role 
for infection of nondividing cells. 
Introduction 
Retroviruses are single-stranded RNAviruses whose repli- 
cation depends on the integration of a double-stranded 
DNA intermediate, termed the provirus, into the host cell 
genome. For oncoretroviruses, this process depends on 
cell proliferation (Humphries and Temin, 1972, 1974), be- 
cause the breakdown of the nuclear envelope at mitosis 
is necessary for bringing the viral preintegration complex 
in contact with the cell chromosomes (Roe et al., 1993; 
Lewis and Emerman, 1994). In contrast, human immuno- 
deficiency virus type 1 (HIV-1) has the ability to infect non- 
dividing cells (Lewis et al., 1992). This property is shared 
with other lentiviruses and reflects the existence of deter- 
minants that govern the active transport of the viral preinte- 
gration complex through the nucleopore (Bukrinsky et al., 
1992). It likely plays a crucial role in AIDS pathogenesis 
because it allows the spread of HIV-1 in such critical tar- 
gets as terminally differentiated macrophages (Weinberg 
et al., 1991). 
Two viral proteins, matrix (MA) and Vpr, have been 
shown to participate in this process in a partly redundant 
manner (Bukrinsky et al., 1993a; Heinzinger et al., 1994; 
von Schwedler et al., 1994). MA is the N-term inal cleavage 
product of the HIV-1 Gag precursor by the viral protease 
and contains a nuclear localization signal (NLS) (Myers 
et al., 1992) that closely resembles the prototypic SV40 
large T antigen NLS (Kalderon et al., 1984). A peptide 
based on the MA NLS acts as a nuclear targeting se- 
quence when coupled to a heterologous protein in vitro 
(Bukrinsky et al., 1993a). In cells acutely infected with H IV-l, 
MA was detected in fractions containing partially purified 
HIV-1 preintegration complexes (Bukrinsky et al., 1993b), 
as well as in the nucleus (Sharova and Bukrinskaya, 1991). 
In the absence of a functional vpr gene, the critical role 
of the MA NLS is further revealed: vpr-MA-NLS double 
mutant viruses show a defect in nuclear import and, as a 
result, have an impaired ability to infect nondividing cells 
such as macrophages (Bukrinsky et al., 1993a; Heinzinger 
et al., 1994; von Schwedler et al., 1994). 
In addition to fulfilling this critical function at an early 
step of the infection process, MA also plays an essential 
role in virus morphogenesis. Indeed, a myristate residue 
at the N-terminus of MA directs Gag to the plasma mem- 
brane. This targeting is essential for the proper assembly 
of viral particles and for their release into the extracellular 
space (Varmus and Swanstrom, 1984). In the process, MA 
also recruits the envelope glycoprotein at the surface of 
virions (Yu et al., 1992a, 1992b; Dorfman et al., 1994). 
Correspondingly, MA has been localized to the periphery 
of mature HIV-1 particles, bound to the inner leaflet of the 
virus lipid bilayer (Gelderblom et al., 1987). 
Since the myristoylation signal and the N LS have oppos- 
ing influences on the subcellular localization of MA, their 
respective effects must be tightly regulated. The present 
work reveals the mechanism of this regulation. We find 
that myristoylation acts as a dominant argeting signal for 
MA in HIV-1 producer cells, preventing the NLS-mediated 
nuclear import of the protein. We further demonstrate that 
a small subset of MA molecules undergo C-terminal tyro- 
sine phosphorylation at the time of particle assembly. Both 
membrane association and proteolytic cleavage of Gag 
are necessary for this modification, which can be observed 
in the absence of other viral proteins. Accordingly, tyrosine 
phosphorylation can be observed when recombinant MA 
is exposed to cellular extracts, as well as viral lysates. 
Although only 1% of all MA molecules internalized by 
newly infected cells migrate to the nucleus, the majority 
of those phosphorylated on tyrosine are rapidly translo- 
cated to this compartment. Mutating the C-terminal tyro- 
sine of MA to phenylalanine does not alter Gag processing, 
nor replication of the resulting virus in dividing cells, such 
as activated T lymphocytes. However, in the absence of 
a functional vpr gene, the MA tyrosine mutant is profoundly 
defective for growth in terminally differentiated macro- 
phages, owing to a block in the nuclear import of the viral 
preintegration complex. These results thus demonstrate 
that tyrosine phosphorylation reveals the karyophilic func- 
tion of MA in the context of the HIV-1 preintegration com- 
plex, thereby playing a crucial role for infection of nonpro- 
liferating cells such as macrophages. 
Cell 
380 
KK*~KLKH 
..... ~ , ,  J-C'~'~!! ! ! !!!!iia ~m ~I 
TTK~LK. 
MAG2A/KK27Tr: A ~ i i i~  ~|~ 
T~KLK*  
S, C 
MA: 
CA: 
CX 
WT MAG2 A 
@ ~ ~ ~ tubulir 
Irealrnent: -- 
1 2 3 4 5 6 1 2 3 4 5 6 7 1 2 3 4 5 6 
Figure 1. Myristoylation Prevents the NLS- 
Mediated Nuclear Import of HIV-1 MA in Pro- 
ducer Cells 
(A) Schematic representation f MA variants 
analyzed in these experiments. 
(B) MA,H~s and MA~, variants are nonmyristoy- 
rated. [3H]myristate-labeled extracts from 293 
cells transfected with proviral constructs ex- 
pressing either wild-type MA, or the two N-ter- 
minus mutated forms of the protein (see [A]), 
were analyzed by immunoprecipitation with 
MA-specific antibody. 
(C) Subcellular localization of MA in trans- 
fected cells. Cytoplasmic (CX) and nuclear 
(NX) fractions of 293 cells transfected with 
DNAs expressing the various forms of MA 
shown in (A) (minus: mock) were analyzed by 
Western blotting, with antibodies against MA 
(top), CA (middle), and tubulin (bottom). Wild- 
type MA (lane 2) is found exclusively inthe cytoplasm, whereas large amounts of the two nonmyristoylated forms of MA (lanes 3 and 5) migrate 
to the nucleus. Nuclear transport of nonmyristoylated MAis greatly reduced by a mutation i  the NLS (lanes 4 and 6). CA and the tubulin control 
are restricted to the cytoplasm. 
(D) Wild-type MA is tightly bound tothe plasma membrane. 293 ceils expressing wild-type and a nonmyristoylated form of MA were separated 
into plasma membrane, cytosol, and nucleus fractions, followed by immunoprecipitation with MA-specific antibody and Western blotting. 
(E) Nuclear import of nonmyristoylated MAis blocked by NLS peptide and wheat germ agglutinin (WGA), 293 cells expressing MAGu, were treated 
overnight as indicated above each lane (minus: mock). Nuclear fractions were then analyzed by immunoprecipitation with MA-specific antibody, 
followed by Western blotting. The effect of WGA could be prevented by addition of N-acetylglucosamine, as described (Forbes, 1992). 
Results 
Myristoylation Prevents the NLS-Mediated 
Transport of MA to the Nucleus 
of HIV-1 Producer Cells 
Altered forms of the HIV-1 MA protein were generated in 
the context of a full-length proviral construct (Figure 1A). 
First, two nonmyristoylated variants were created, one by 
replacing the MA N-terminal glycine by alanine, the sec- 
ond by introducing six histidines at the proximal end of 
Gag. Both mutations effectively prevented myristoylation 
(Figure 1 B). N LS-defective versions of these proteins were 
also derived by replacing two lysines in the NLS by threo- 
nines, a change previously shown to abrogate the function 
of this motif (von Schwedler et al., 1994). Cytoplasmic and 
nuclear extracts of cells transfected with these constructs 
were then analyzed by Western blotting (Figure 1C). Wild- 
type MA was found exclusively in the cytoplasm (Figure 
1C, lane 2), as was the viral capsid (CA); tubulin, a protein 
normally restricted to this compartment, sewed as a con- 
trol. Further separation of the cytoplasm in membrane and 
cytosol fractions revealed that myristoylated MA was asso- 
ciated with the plasma membrane, as previously de- 
scribed (Varmus and Swanstrom, 1984; Spearman et al., 
1994) (Figure 1D, lanes 1-3). In contrast, large amounts 
of both forms of nonmyristoylated MA were associated 
with the nucleus (Figure 1C, lanes 3 and 5; Figure 1D, 
lanes 4-6). This process was NLS-dependent, since muta- 
tions in this motif induced the partial redistribution of non- 
myristoylated MA to the cytoplasm (Figure 1C, lanes 4 
and 6). Furthermore, the nuclear import of nonmyristoy- 
lated MA was effectively blocked by peptide containing 
the prototypic SV40 large T antigen NLS (Figure 1 E, lanes 
1-4). This correlates the previous demonstration that such 
peptide can inhibit the MA-mediated nuclear import of the 
HIV-1 preintegration complex (Gulizia et al., 1994), as well 
as that of other karyophiles harboring a related signal (Mi- 
chaud and Goldfarb, 1993). Finally, nuclear import of non- 
myristoylated MA could be prevented by wheat germ ag- 
glutinin (Figure 1E, lanes 5-7), a lectin that specifically 
blocks transport through the nuclear pore (reviewed by 
Forbes, 1992). 
In these experiments, MA was expressed together with 
the other products of the gag and pol genes, raising the 
possibility that these additional polypeptides altered its 
localization. These studies were thus repeated with HIV-1- 
derived constructs in which the sequence encoding wild- 
type or nonmyristoylated MA was immediately followed by 
a stop codon. The respective distribution f these proteins 
was similar to that observed in the context of full-length 
precursors, indicating that MA subcellular targeting is in- 
dependent from other Gag and Pol proteins (data not 
shown). 
MA Molecules Imported to the Nucleus of Newly 
Infected Cells Are Myristoylated 
The above data indicate that MA has intrinsic nucleophilic 
properties conferred by the NLS, but in virus producer 
cells, these are masked by myristoylation. Yet, once HIV-1 
enters target cells, a functional MA NLS prevails and plays 
a major role in facilitating the nuclear import of the viral 
preintegration complex (Bukrinsky et al., 1993a; von 
Schwedler et al., 1994). One possible explanation for this 
paradox was that some unmyristoylated MA was incorpo- 
rated in vidons and was selectively imported to the nucleus 
of newly infected cells. Alternatively, proteolytic leavage 
could occur on a subset of MA molecules, removing the 
myristoylated N-terminus. To test these hypotheses, growth- 
arrested cells were acutely infected with viruses labeled 
with either [3sS]cysteine or [3H]myristic acid. Cytoplasmic 
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Figure 2. MAMoleculeslmportedtotheNucleusofHIV-1TargetCells 
Are Myristoylated 
Cytoplasmic (CX) and nuclear (NX) fractions of y-irradiated P4-2 cells 
acutely infected with virions purified from Molt IIIB cells labeled with 
either pS]cysteine (A) or [3H]myristate (B) were immunoprecipitated 
with MA-specific antibody. V, virions. After autoradiography, bands 
were excised and counted; the number of cpm recovered in each 
case is shown. Approximately 1% of internalized MA molecules, fully 
myristoylated, migrate to the nucleus of acutely infected cells. 
and nuclear extracts, prepared at 6 hr postinfection, were 
then analyzed for their respective MA contents. This re- 
vealed that approximately 99% of internalized MA mole- 
cules were found in a cytoplasmic fraction (Figure 2), 
mostly in association with the plasma membrane (data not 
shown). In contrast, 1% of MA molecules were present in 
a nuclear fraction. An identical nucieocytoplasmic ratio for 
MA was obtained when radioactive counts obtained from 
[3sS]cysteine- or from [3H]myristic acid-labeled protein 
were used to calculate this number. On that basis, it can 
be inferred that MA molecules associated with the nucleus 
of newly infected cells are fully myristoylated. 
The C-Terminal Tyrosine of MA Is Phosphorylated 
Taken together, these results demonstrate that myristoy- 
lation acts as a dominant argeting signal for MA during 
viral particle formation, yet for 1% of the molecules, it 
becomes recessive once HIV-1 enters target cells. This 
suggests a model in which some modification of MA, dur- 
ing or after assembly, is responsible for silencing the influ- 
ence of myristoylation, thereby revealing the NLS effect. 
Interestingly, the membrane association of HIV-1 Gag de- 
pends not only on myristate, but also on nearby positively 
charged residues predicted to interact with negatively 
charged phospholipids in the plasma membrane (Zhou et 
al., 1994). Such an electrostatic mechanism implies that 
reversible membrane binding of MA might be achieved 
by introduction of appropriately placed negative charges 
into the protein, for instance through phosphorylation. By
analogy, platelet-derived growth factor stimulation of 3T3 
cells is accompanied by N-terminal phosphorylation of 
myristoylated pp60 °src, which is then released from the 
cell membrane (Walker et al., 1993). Similarly, phosphory- 
lation of membrane-bound myristoylated alanine-rich C 
kinase substrate (MARCKS) by protein kinase C releases 
this protein into the cytosol (Thelen et al., 1991). 
Based on these precedents, the phosphorylation status 
of HIV-1 MAwas examined. It was thus found that, in HIV-1 
virions purified from acutely infected T lymphoid cells, MA 
treatment: 
(z-MA: 
_ o ~  x 
c~-pTyr: 
p17-IP' 
1 2 3 
B 
c~-MA: 
pt7"1~' 
pl 7 " 1 ~ ~  
c~-pTyr: 
1 2 3 
@ 
4 5 6 7 
KKKYKLKH Y VSQNYPIVQN 
myr-G ~ 
C 
-Fil l  -F~I. 
Figure 3. HIV-1 MA Is Phosphorylated on C-Terminal Tyrosine 
(A) Lysates of virions purified from HIV-l-infected CEM cells were 
analyzed by Western blotting with MA- and phosphotyrosine-specific 
antibodies, as indicated, with or without prior treatment with phospha- 
tase (CIP), or phosphatase plus orthovanadate (CIP + OV). 
(B) The same analysis, on virions produced by transfection of 293 
cells with constructs containing indicated tyrosine-to-phenylalanine 
mutations in MA. The C-terminal tyrosine of MA (Y132) is the target 
of phosphorylation. 
(C) Two-dimensional phosphoamino acid analysis of s2P-labeled MA 
(wild type and Y132F) from virions isolated from infected CEM cells. 
Wild type (WT) contains phosphoserine and phosphotyrosine; MAy132F 
contains phosphoserine only. 
reacted with an anti-phosphotyrosine antibody in Western 
blots (Figure 3A, lane 1). The signal could be abolished 
by prior treatment of viral extracts with calf intestine phos- 
phatase (Figure 3A, lane 2), unless the phosphatase inhibi- 
tor orthovanadate was added (Figure 3A, lane 3). MA tyro- 
sine phosphorylation was not restricted to T cell-produced 
virus, as it was also observed with virions purified from 
the supernatant of transfected fibroblasts (Figure 3B). 
HIV-1 MA contains three highly conserved tyrosines, at 
positions 29, 86, and 132, respectively (Myers et al., 1992). 
Each of these tyrosines was changed individually to phe- 
nylalanine, in the context of a full-length proviral construct. 
Virions obtained from cells transfected with the resulting 
plasmids were analyzed by anti-phosphotyrosine Western 
blotting (Figure 3B). This identified the C-terminal tyrosine 
of MA, at position 132, as the target of phosphorylation. 
Phosphoamino acid analysis of virions produced from 32p. 
labeled cells confirmed that MA is phosphorylated on Tyr- 
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Figure 4. Requirements of MA Tyrosine Phosphorylation 
(A) 293 cells stably expressing various forms of Gag (Figure 1 ; MAsTop 
encodes a truncated Gag precursor, owing to a stop codon right after 
the MA coding sequence), or a protease-defective provirus (APro), 
were analyzed by Western blotting with MA-, CA- and phosphotyrosine- 
specific antibodies as indicated. MA tyrosine phosphorylation depends 
on myristoylation and proteolytic cleavage of Gag. 
(B) The same analysis on 293 cells transiently transfected with vectors 
expressing a CD4/MA chimera represented below blot, with tyrosine 
(44MA) or phenylalanine (44MAy~32F) at the MA C-terminus. MA under- 
goes tyrosine phosphorylation when recruited to the membrane as 
part of an integral membrane protein. 
132, as well as on serine (Figure 3C). Furthermore, radio- 
active measurements,  done by comparing the amounts 
of [~S]cysteine and 32p incorporated in virus-associated 
MA when producer cells were labeled for 2 days, indicated 
that approximately lS/o of MA molecules present in virions 
are phosphorylated (data not shown). 
Requirements for MA Tyrosine Phosphorylation 
The requirements for MA tyrosine phosphorylation were 
then determined. It revealed that this modification was 
dependent on the plasma membrane association of Gag, 
as nonmyristoylated forms of MA were not tyrosine phos- 
phorylated (Figure 4A, lanes 1 and 2). If MA was produced 
in the absence of other Gag and Psi proteins, its exposed 
C-terminus underwent tyrosine phosphorylation (Figure 
4A, lane 4). However,  no phosphotyrosine was detected in 
the p55 Gag precursor, whether it was produced in normal 
amounts by wild-type virus or accumulated by a protease- 
defective mutant (Figure 4A, lane 5). The need for Gag 
proteolytic leavage implies that MA tyrosi ne phosphoryla- 
tion is coupled with virus maturation, as might be expected 
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Figure 5. MA Protein Kinase Activity in Cells and in Virions 
(A) In vitro phosphorylation of recombinant wild-type and Y132F MA 
protein, using [7-32P]ATP and pelleted supernatant from human T 
lymphoid CEM cells (PCS). After reactions were performed as indi- 
cated, MA was purified on a nickel column, resolved by SDS-PAGE, 
and transferred to a PVDF membrane that was exposed to X-ray film. 
(B) Two-dimensional phosphoamino acid analysis of in vitro phosphor- 
ylated recombinant MA recovered from (A), showing incorporation f 
phosphate on serine, threonine and tyrosine in the case of wild-type, 
and on serine and threonine only in the case of MAY132F. 
(C, left panel) in vitro phosphorylation of recombinant MA, using 
[y;32P]ATP and fractions from a Sephacryl S-1000 gel filtration purifica- 
tion of HIV-1 virions from chronically infected Molt IIIB cells. Curve 
indicates p24 antigen content of each fraction. Phosphoamino acid 
analysis (inset) shows that serine, threonine, and tyrosine kinase activi- 
ties are associated with HIV-1 particles. 
(C, right panel) Virions present in fractions 3 and 4 were further immu- 
noprecipitated with a mixture of gp120 and gp41 antibodies, or with 
a control antiserum; the products were then used in an in vitro kinase 
assay with recombinant MA as substrate. Lane 1, crude viral pellet; 
lane 2, Sephacryl S-1000-purified virions; lane 3, as lane 2, followed 
by immunoprecipitation with envelope-specific antibodies; lane 4, as 
lane 2, followed by immunoprecipitation with control serum, lane 5, 
negative control (no lysate). The amount of p24 antigen present in 
each sample is indicated below each lane. 
for a regulatory event controlling, in a t imely manner, the 
karyophil ic properties of this protein. 
To explore further the factors important for MA tyrosine 
phosphorylation, a chimeric integral membrane protein 
was constructed, with an extracellular and transmem- 
brane region derived from CD4 and a cytoplasmic domain 
made by MA. A variant of this chimera, in which the C-ter- 
minal tyrosine of MA was changed to phenylalanine, served 
as control. These proteins, called 44MA and 44MAyt32F, 
respectively, were then analyzed by Western blotting with 
MA- and phosphotyrosine-specif ic antibodies (Figure 4B). 
The result showed that the tyrosine phosphorylation of the 
MA C-terminus occurred efficiently in the 44MA protein. 
It confirmed that this process is independent of the recog- 
nition of a specific receptor by the myristoylated end of 
MA. Furthermore, it demonstrated that MA tyrosine phos- 
phorylation does not require particle formation per se, nor 
the presence of any other viral protein. 
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Figure 6. Tyrosine-Phosphorylated MA Is Rapidly Transported to the 
Nucleus of Acutely Infected Cells 
Cytoplasmic and nuclear fractions of ,'/-irradiated P4-2 cells acutely 
infected either by coculture (at a ratio of 50:1 with Molt IIIB cells) (A) 
or with cell-free virions (5 Ilg of p24) (B), harvested at the indicated 
times postinfection, were analyzed by immunoprecipitation with anti- 
MA antibody, followed by Western blotting with MA- or phoephotyro- 
sine-specific antibody. Whereas the majority of MA remains in the 
cytoplasm (associated with the plasma membrane, .data not shown), 
most tyrosine-phosphorylated MA rapidly migrates to the nucleus. 
((3) Cell-free infection repeated in the presence of NLS peptide (500 
IIM). Nuclear import of MA is blocked, but tyroeine-phosphorylated 
species are still detected, demonstrating that they are not generated 
in the nucleus. 
The pattern of tryptic phosphopeptides of phosphorylated 
MA molecules obtained in these experiments was exam- 
ined and found to be comparable to that observed with 
virus-associated MA labeled in vivo (data not shown). Sig- 
nificant levels of MA serine, threonine, and tyrosine kinase 
activities were also found in HIV-1 virions, purified from 
a chronically infected human T lymphoid cell line by size 
fractionation (Figure 5C, left). Moreover, the MA protein 
kinase activity remained associated with the viral particles 
when these were purified further by immunoprecipitation 
with antibodies against the viral envelope (Figure 5C, 
right). 
Tyrosine-Phosphorylated MA Is Rapidly Imported 
to the Nucleus of Newly Infected Cells 
To ask whether tyrosine phosphorylation influences the 
karyophilic properties of MA, growth-arrested cells were 
exposed to HIV-1 and fractionated in cytoplasmic and nu- 
clear fractions, at various times postinfection. These frac- 
tions were then analyzed by Western blotting, with MA- 
and phosphotyrosine-specific antibodies (Figures 6A and 
6B). As seen previously (Figure 3), the vast majority of 
MA molecules remained associated with the cytoplasm. 
In contrast, most of those phosphorylated on tyrosine were 
rapidly transported to the nucleus. If cells were treated 
with NLS peptide, total levels of phosphotyrosine-con- 
taining MA were not significantly changed, but this protein 
was retained in the cytoplasm (Figure 6C). This indicates 
that the nuclear accumulation f tyrosine-phosphorylated 
MA does not reflect de novo phosphorylation i this com- 
partment, but instead the rapid and preferential transloca- 
tion of this protein from the cytoplasm to the nucleus of 
acutely infected cells. 
MA Tyrosine Phosphorylation Is Accomplished by 
a Cellular Protein Kinase Present in Virions 
The last point implied that a cellular kinase is responsible 
for MA tyrosine phosphorylation. This was tested by in 
vitro kinase assays employing recombinant MA protein as 
substrate (Figure 5). When incubated in the presence of 
reaction buffer and ATP, MA did not autophosphorylate. 
In contrast, phosphate moieties were transferred from 
[y-32P]ATP to MA, when either crude extracts of CEM or 
293 cells or pelleted CEM supernatant were added (Figure 
5A). Greater levels of 3~p incorporation were seen when 
pelleted cell supernatant, as opposed to cellular extract, 
was used as the source of protein kinase activity. However, 
this was due to higher levels of endogenous ATP in the 
cells, which interfered with the incorporation of 32p into the 
MA substrate: when reactions were normalized by adding 
nonradioactive ATP to 20 raM, cell extracts were found 
to be more effective at phosphorylating MA (data not 
shown). In these in vitro assays, incorporation of phos- 
phate was less efficient on tyrosine than on serine, and 
some phosphothreonine was also observed, whereas 
none was found with in vivo labeled MA. However, the 
C-terminal tyrosine of MA was specifically modified, as 
no phosphotyrosine was recovered when reactions were 
performed on a recombinant MAy~32F variant (Figure 5B). 
An HIV-1 Strain Defective for MA Tyrosine 
Phosphorylation Is Blocked for Growth in 
Terminally Differentiated Macrophages 
Owing to a Defect in Nuclear Import 
Our findings were compatible with a role for MA tyrosine 
phosphorylation in HIV-1 nuclear import and, hence, for 
infection of nondividing cells. To probe this issue, the repli- 
cation of viruses containing wild-type and phosphotyro- 
sine-defective versions of MA were compared under con- 
ditions of cell proliferation and growth arrest. A virus with 
a mutation in the MA NLS served as additional control, 
as it was previously shown to be defective specifically in 
nondividing cells (von Schwedler et al., 1994). Since Vpr 
can partly substitute for MA in facilitating the nuclear mi- 
gration of HIV-1 in nonmitotic targets (Heinzinger et al., 
1994), these experiments were done with viral strains car- 
rying a defective vprgene. Substituting aphenylalanine for 
the C-terminal tyrosine of MA did not alter Gag processing 
(Figure 3) nor replication of the resulting HIV-1 mutant in 
activated peripheral blood lymphocytes (Figure 7, top). 
However, like the MA NLS mutant, this variant was unable 
to grow in terminally differentiated macrophages (Figure 
7, bottom). 
To examine further this parallel and to determine the 
level at which the replication of the tyrosine mutant was 
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Figure 7. MA Phosphotyrosine Mutant HIV-1 Is Unable to Grow in 
Macrophages 
Growth of NLS-defective (MAKK2rcrR7Bak) and MA phosphotyrosine- 
defective viruses (MA¥132FR7BaL) were compared with that of the wild- 
type parent (R7Bak) in PHA-activated PBL (top) and terminally differen- 
tiated macrophages (bottom). The T cell tropic strain R7, which cannot 
infect macrophages, served as control. All viruses encode a truncated 
Vpr that cannnot substitute for MA NLS function in macrophages (yon 
Schwedler et al., 1994). 
blocked, viral DNA synthesis in freshly infected macro- 
phages was studied. The accepted model for reverse 
transcription includes a series of steps, beginning with the 
synthesis of DNA complementary to the U5 and R regions 
of the viral long terminal repeat (minus-strand strong-stop 
DNA), continuing with the elongation of this minus-strand 
after a first template switch, and culminating in the genera- 
tion of a full-length double-stranded DNA molecule follow- 
ing a second template switch. Once the viral DNA is trans- 
ported to the nucleus, full-length linear molecules can 
circularize either by ligation of their two ends or through 
recombinatorial events (Varmus and Swanstrom, 1984). 
The appearance of these various intermediates and prod- 
ucts of reverse transcription was thus monitored by poly- 
merase chain reaction (PCR), in terminally differentiated 
macrophages acutely infected with the HIV-l-derived vi- 
ruses (Figure 8). This revealed that the phosphotyrosine- 
defective virus directed the synthesis of wild-type amounts 
of viral linear DNA, indicating that its entry and reverse 
transcription proceeded normally. In contrast, and like the 
NLS mutant, this variant produced much lower levels of 
viral DNA circles compared with wild type. These results 
indicated that the absence of tyrosine at the C-terminal 
end of MA specifically impairs the nuclear import of HIV-1 
DNA. These data thus allow us to conclude that tyrosine 
phosphorylation reveals the karyophilic properties of MA 
in the context of the HIV-1 preintegration complex, thereby 
playing an esential role for infection of terminally differenti- 
ated macrophages. 
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Figure 8. Nuclear Import of MA Phosphotyrosine Mutant HIV-1 Is De- 
fective in Macrophages 
Terminally differentiated macrophages infected with wild-type MA
(a: R7BaL), MA phosphotyrosine-defective (b: MA¥132~R7BaL), or
NLS-defective (c: MAKK2TI-FR7BaL) viruses (all of which encode a 
nonfunctional Vpr protein) were analyzed by PCR at the indicated 
timepoints, with primers pecific for various products of reverse trans- 
cription. EL, early linear products (elongated minus-stand DNA); LL, 
late linear products (generated after the second template switch); Ci, 
two-LTR circles (formed in the nucleus). Both MA mutants induce wild- 
type levels of linear DNA but dramatically reduced amounts of circles. 
Discussion 
The HIV-1 MA protein fulfills two crucial functions at differ- 
ent stages of the virus life cycle, as it is required for both 
particle assembly and nuclear import of the viral preinte- 
gration complex. The myristoylation signal and the NLS, 
which exert contradictory influences on the subcellular lo- 
calization of MA, are each essential for one of these two 
functions. Here, we present a model for the regulatory 
mechanism that allows MA to play its dual role. We first 
show that myristoylation acts as a dominant argeting sig- 
nal for MA in virus producer cells, leading to particle forma- 
tion at the plasma membrane and release of new virions 
into the extracellular space. We then demonstrate that a 
small subset of MA molecules undergo tyrosine phosphor- 
ylation. The dependence of this process on both mem- 
brane association and proteolytic cleavage of Gag sug- 
gests that it occurs concomitantly with virus maturation. 
A protein kinase activity that transfers phosphate to the 
C-terminal tyrosine of recombinant MA can be detected 
in cells as well as in purified virions. A crucial link between 
MA tyrosine phosphorylation and the subsequent import 
of the HIV-1 preintegration complex is revealed by two 
lines of evidence. First, there is rapid translocation of tyro- 
sine-phosphorylated MA to the nucleus of newly infected 
cells, whereas the bulk of MA, not phosphorylated on tyro- 
sine, remains at the plasma membrane. Second, a mutant 
virus in which the critical MA tyrosine is changed to phen- 
ylalanine is selectively impaired for growth in terminally 
differentiated macrophages, owing to a block in nuclear 
import. 
MA Tyrosine Phosphorylation and HIV-1 Nuclear 
Import: Potential Mechanisms 
The nucleophilic properties of several other proteins are 
derepressed following phosphorylation, For instance, treat- 
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ment of cells with interferon-a (IFN-~) induces tyrosine 
phosphorylation and nuclear translocation of the IFN-cc- 
stimulated gene factor 3 (ISGF3), a transcriptional regula- 
tor involved in mediating cellular responses to the cytokine 
(Schindler et al., 1992). In that case, an interaction be- 
tween the phosphotyrosine and an SH2 domain mediates 
the dimerization of the protein, perhaps exposing a yet 
unidentified nucleophilic motif (Shuai et al., 1994). Also, 
the nuclear import of SV40 large T antigen is significantly 
reduced when sequences flanking the NLS and containing 
casein kinase II (CKII) phosphorylation sites are removed 
(Rihs and Peters, 1989). This might reflect an increased 
affinity of phosphorylated T antigen for a cytoplasmic re- 
ceptor responsible for its routing to the nuclear envelope. 
It is likely that tyrosine phosphorylation enhances the 
nuclear transport of HIV-1 MA through a different mecha- 
nism. Indeed, nonmyristoylated MA is effectively imported 
to the nucleus even though it is not tyrosine phosphory- 
lated (Figures 1 and 4). Based on this, it is probable that 
phosphorylation triggers the redistribution of MA from the 
membrane to the inner region of the virus, thereby allowing 
the NLS to play its role in the context of the viral preintegra- 
tion complex. This could be accomplished by at least two 
nonmutually exclusive mechanisms: by simply disrupting 
interactions between MA and the viral membrane, or by 
stimulating the binding of MA to another component of 
the viral core nucleoprotein complex. 
Membrane release of MA could result from a major con- 
formational change in the protein following phosphoryla- 
tion. However, a more subtle mechanism could achieve 
the same result. Indeed, the proximal region of HIV-1 Gag 
contains a bipartite membrane targeting signal, compris- 
ing the myristoylated N-terminal 14 residues, plus an adja- 
cent sequence of 17 amino acids, a number of which are 
positively charged (Spearman et al., 1994; Zhou et al., 
1994). This more distal region, which has been shown to 
bind to acidic phospholipids in vitro (Zhou et al., 1994), is 
predicted to establish electrostatic interactions with nega- 
tively charged phospholipids located on the inner leaflet 
of the membrane bilayer. Thus, by introducing negative 
charges in MA, phosphorylation could disrupt these inter- 
actions, thereby releasing the protein from the plasma 
membrane. A similar mechanism has been shown to ac- 
count for the release of myristoylated pp60 ~~'° and MARCKS 
from the plasma membrane into the cytosol following 
phosphorylation by protein kinases A and C, respectively 
(Walker et al., 1993; Thelen et al., 1991). With MA, detach- 
ment from the membrane would unleash the karyophilic 
potential conferred by the NLS. 
However, two arguments can be advanced against this 
simple model. First, the tyrosine that becomes phosphory- 
lated is at a significant distance from the region of MA 
involved in membrane binding, not only considering a lin- 
ear map of the protein but also its recently proposed struc- 
ture (Matthews et al., 1994). Second, tyrosine-phosphor- 
ylated MA is detected in virus producer or MA-expressing 
cells (Figure 1; data not shown), yet in these cells it re- 
sides in the cytoplasm but not the nucleus. This suggests 
that an additional factor potentiates the effect of MA tyro- 
sine phosphorylation once HIV-1 leaves producer cells. 
On the one hand, there could be an additive effect of MA 
serine phosphorylation, and in agreement with such a 
model, our preliminary studies indicate that this modi- 
fication too is coupled to virus maturation (S. S. and 
D. T., unpublished ata). Alternatively, itcould be that MA 
is preferentially released from the membrane of virions 
rather than from the membrane of virus producer cells. In 
that respect, the fluidity and lipidic composition of the 
HIV-1 membrane have been shown to significantly differ 
from those of the host cell plasma membrane (Aloia et al., 
1993). Finally, tyrosine phosphorylation could trigger an 
association between MA and one of the proteins that are 
directed to the central region of the core during virus matu- 
ration and are ultimately involved in forming the virus pre- 
integration complex, such as the integrase and the reverse 
transcriptase. The nuclear magnetic resonance analysis 
of MA predicts that the C-terminal 20 amino acids of the 
protein do not adopt a rigid conformation and, therefore, 
might be available for such an interaction (Matthews et 
al., 1994). 
An implication of all the above models is that tyrosine- 
phosphorylated MA molecules might be found inside the 
viral core. Previous immunoelectron microscopic studies 
have instead localized MA at the periphery of virions, 
tightly bound to the inner leaflet of the virus membrane 
(Gelderblom et al., 1987). However, of the 1500 MA mole- 
cules estimated to be present in each virion (Gelderblom, 
1991), on the basis of our data, we would not expect more 
than 1° ,  or approximately 15, to be associated with the 
core. Indeed, this represents the fraction subsequently 
imported to the nucleus of newly infected cells (Figure 3). 
It is reasonable to assume that such a small number of 
MA molecules would have escaped detection by electron 
microscopy. Another prediction derived from our experi- 
ments is that, following fusion of the virus and target cell 
membranes, tyrosine-phosphorylated MA molecules are 
the ones whose NLS is recognized by a cytoplasmic hap- 
erone responsible for leading the preintegration complex 
to the nucleopore (Adam and Gerace, 1991; Forbes, 
1992). Our preliminary analyses show that MA molecules 
contained in the preintegration complex are indeed phos- 
phorylated on tyrosine, supporting this hypothesis (P. G. 
and D. T., unpublished data). 
A Virus-Associated Cellular Protein Kinase 
Responsible for MA Tyrosine Phosphorylation 
The data presented here provide strong evidence indicat- 
ing that MA tyrosine phosphorylation is accomplished by 
a cellular protein kinase. The MA tyrosine kinase activity 
is not restricted to T lymphocytes but is also found in fibre- 
blasts. It fails to phosphorylate nonmyristoylated MA, and 
so it is likely associated with the cell membrane. This activ- 
ity can also be detected in the cell supernatant, most prob- 
ably due to cellular breakdown, rather than to secretion. 
Remarkably, the MA tyrosine kinase is present in HIV-1 
virions purified by size fractionation followed by immune- 
precipitation with anti-envelope antibodies. Whether this 
reflects the stable binding of the enzyme to its MA sub- 
strate or the passive incorporation of a membrane-bound 
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enzyme in budd ing  v ir ions is still to be def ined.  The  target 
of  the tyros ine k inase  is the last amino acid of  MA, a pre- 
v ious ly  unseen p lacement  for a phosphotyros ine .  Only  the 
f ree end of  MA is recognized,  e i ther  after  it is l iberated by 
proteolyt ic  c leavage of  the Gag precursor  or when it is 
natural ly  exposed ,  for instance in the MAsToP and 44MA 
molecu les  (F igure 4). This  appears  to permit  a coupl ing 
between v i rus  maturat ion  and  MA ty ros ine  phosphor -  
ylation. 
The  MA tyros ine k inase remains  to be formal ly  identi-  
f ied. However ,  the present  work  estab l i shes  that it p lays 
a crucial  role in faci l i tat ing HIV-1 repl icat ion in terminal ly  
d i f ferent iated macrophages ,  cel ls thought  to be critical for 
both the pers is tence and the d isseminat ion  of  the infect ion 
(Gartner  and Popovic,  1990). Efforts a imed at ident i fy ing 
compounds  that  b lock MA tyros ine phosphory la t ion  are 
thus warranted,  as they may lead to novel  therap ies  for 
s lowing the spread  of  the virus in HIV- infected individuals.  
Experimental Procedures 
DNA Constructions 
PCR-mediated mutagenesis was used to introduce site-specific muta- 
tions in the MA- or protease-encoding regions of plasmid R7 (Kim et 
al., 1989; yon Schwedler et al., 1993), which contains the HIV-1HXB2D 
provirat DNA (Shaw et al., 1984) with a full-length nef reading frame, 
as well as in R7BaL, which encodes a macrophage-tropic virus (von 
Schwedler et al., 1994). Both R7 and R7BaL produce a truncated Vpr 
protein, 78 amino acids in length, previously shown to be unable to 
substitute for the NLS function of MA in macrophages (von Schwedler 
et al., 1994). The MAG~ variant has the N-terminal glycine of Gag 
changed to alanine. The proximal sequence of the MA,H,, protein is 
Met/Gly/(His)JSer, in which Ser is normally the sixth residue of Gag. 
APro has a 45 nt deletion in the pol gene (bases 2384-2428, as num- 
bered by Ratner et al., 1985). The various mutations were also intro- 
duced in a modified proviral DNA construct, 3E-neo, which expresses 
an env-defective version of R7 and contains the sequence encoding 
for neomycin phosph0transferase instead of nef (Trono, 1992). The 
44MA and 44MA~132F chimeras were constructed by PCR, introducing 
a unique cloning site at the junction between the transmembrane re- 
gion of CD4 and the N-terminal end of MA, in the context of a CMV- 
based expression vector (Aiken et al., 1994). Recombinant MA carrying 
an N-terminal histidine tag was produced in Escherichia coil using the 
bacterial expression vector pET-15b (Novagen) and purified by affinity 
chromatography on a nickel-Sepharose column according to the in- 
structions of the manufacturer. 
Cells 
All cells were maintained as previously described (Aiken et al., 1994; 
von Schwedler et al., 1994). HIV-t-infected Molt IIIB human T lymphoid 
cell lines were obtained from C. Farnet through the NIH AIDS Research 
and Reference Program. HeLa-derived P4-2 cells (Charneau et al., 
1990) were a gift from F. Clavel. Peripheral blood lymphocytes (PBLs) 
and monocyte-derived macrophages were purified as previously de- 
scribed (von Schwedler et al., 1994). Macrophages were kept in culture 
for 2 weeks before infection. For stimulation, PBLs were incubated 
with phytohemagglutinin (Bethesda Research Laboratories) at 3 ~g/ 
ml for 48 hr and then maintained in RPMI 1640 containing 10% fetal 
calf serum and recombinant interleukin-2 (Sigma) at 10 U/ml. To induce 
growth arrest, P4-2 cells were exposed for 20 min to a 61Co source 
calibrated at 200 rad/min. After irradiation, cells were diluted for infec- 
tion to 1 x 106/ml and plated. The arrested state of the cells at the 
time of infection was verified by propidium iodide staining of their DNA 
and flow cytometry to ascertain that all cells were in the G2 phase of 
the cycle. Stable 293 cell lines expressing various MA variants, as 
well as APro, were created by transfection with LIE-neo-derived plas- 
raids and selection in 0.5 mg/ml G418. 
TransfecUons and Infections 
Tranfections and preparations of viral stocks were as previously de- 
scribed (von Schwedler et al., 1993; Aiken et al., 1994). Infections of 
PBLs (2 x 106 cells) and macropbages (0.5 x 10 e cells) were per- 
formed with 20 ng of p24 of 293 cell-produced viruses as previously 
described (von Schwedler et al., 1994). For virus growth curves, cells 
were washed extensively after virus adsorption and p24 antigen pro- 
duction was monitored by ELISA (DuPont). Experiments were re- 
peated many times with cells from different donors, with similar resu Its. 
In rare instances, however, both NLS and tyrosine mutants showed 
a less pronounced phenotype, perhaps linked to the state of arrest 
or differentiation of the macrophages. To follow MA nuclear import, 
infections of P4-2 irradiated cells were performed either by coculture 
with Molt IIIB cells at a ratio of 50 to 1, or by the addition of cell-free 
virus purified from the same cells (5 p.g of p24 antigen per 3 x 107 
P4-2 cells). In the experiments of Figure 2, infections were performed 
using cell-free virus produced by Molt IIIB cells radiolabeled for 20 hr, 
either with 200 p.Ci/ml of Tran~S-label (ICN) or with 500 i~Ci/ml of 
[3H]myristic acid (Amersham). Virions used for in vitro kinase assays 
were prepared by gel fractionation on a Sephacryl S-100O column as 
previously described (Trono, 1992). 
Western Blots and Immunoprecipitstions 
Rabbit anti-HIV-1 MA serum was obtained by immunization with the 
above described recombinant histidine-tagged HIV-1 MA protein. 
Monoclonal antibodies against p24/p55 (ST-3) and tubulin were pur- 
chased from Bethesda Research Laboratories and Boehringer Mann- 
helm, respectively. Rabbit anti-phosphotyrosine s rum was a gift from 
B. Seffon, Salk institute. Of note, several commercially available anti- 
phosphotyrosine monoclonal antibodies failed to recognize the tyro- 
sine-phosphorylated form of MA. Western blot and immunoprecipita- 
tion studies were as previously described (Aiken et al., 1994). 
Subcellular FracUonation 
Cells were lysed in cold hypotonic buffer (20 mM potassium HEPES 
[pH 7.8], 5 mM potassium acetate, 0.5 mM MgCI2, 0.5 mM dithiothreitol, 
1 mM sodium orthovanadate, 1 p.g/ml leupeptin, 1 p~g/ml aprotinin, 1 
~g/ml pepstatin A, 1 mM phenylmethylsulfonyl fluoride [PMSF]) using 
several strokes of a Dounce homogenizer as described by Sugasawa 
et al. (1990). Nuclear preservation during cell lysis was followed by 
phase-contrast microscopy. Cytoplasmic and nuclear extracts were 
separated by centrifugation at 750 x g for 5 rain, and nuclei were 
extracted with a hypertonic buffer (20 mM potassium HEPES [pH 7.8], 
0.5 mM MgCI2, 500 mM potassium acetate, 0.5 mM dithiothreitol, 1
mM sodium orthovanadate, 1 p.g/ml leupeptin, 1 ~g/ml aprotinin, 1 
p.g/ml pepstatin A, 1 mM PMSF). Membrane and cytosol fractions were 
isolated from cytoplasmic extracts as described (Lin et al., 1991). High 
pressure liquid chromatography (H PLC)-purified peptides correspond- 
ing to the prototypic SV40 T antigen NLS in the sense (PKKKR- 
KVEDPYC) and reverse (PDEVKRKKKPYC) orientations were used 
as described (Gulizia et al., 1994). Wheat germ agglutinin (WGA) was 
used at 10 I~M, with or without addition of N-acetylglucosamine (450 
I~M), as described in Finlay et al. (1987). 
Phosphorylation Studies 
HIV-1 DNA (40 I~g) was transfected into 5 × 106 CEM ceils by electro- 
poration. At the peak of p24 viral antigen production, ceils were radiola- 
beled with 35 mCi of ~P H3PO4 (DuPont) for 48 hr at 37°C. Labeled 
virions were first filtered and pelleted, and then incubated for 10 rain 
in viral lysis buffer (12 mM Tris-HCI [pH 8.0], 0.5% Triton X-100, 300 
mM NaCI, 1 mM MgCI2, 0.5 mM dithiothreitol, and 100 rim sodium 
orthovanadate). MA protein was the n immunoprecipitated with a mono- 
clonal anti-HIV-1 IIIB MA antibody (Advanced Biotechnologies Inc.)on 
protein A-Sepharose beads. After SDS-PAGE and electrobiotting to 
polyvinylidene difluoride (PVDF) membrane, phosphorylated MA was 
visualized by autoradicgraphy and analyzed further for phosphoamino 
acid content, essentially as described by Boyle et al. (1991). 
PCR Analysis of Acutely Infected Cells 
PCR analysis was performed as previously described (yon $chwedler 
et al., 1993). The sequences of HIV-specific primers are as follows 
(positions of nucleotides in the HIV-1H×B~D sequence, according to 
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Ratner etal. [1985], are indicated in parentheses). Vif6: GGGAAAGC- 
TAGGGGATGGI-]TTAT (5136-5159); Vif?: CAGGGTCTACTTGTGT- 
GCTATTC (5340-5317); LTR5: GGCTAACTAGGGAACCCACTGCTT 
(496-516); 5NC2: CCGAGTCCTGCGTCGAGAGAGC (698-677); LTRS, 
TCCCAGGCTCAGATCTGGTCTAAC (488-465 and 9572-9549); LTRg, 
GCCTCAATAAAGCTTGCCTTG (522-542 and 9606-9626). Vif6 plus 
Vif7 amplify elongated minus-strand DNA, LTR5 plus 5NC2 amplify 
double-stranded molecules generated after the second template 
switch, and LTR8 plus LTR9 amplify two-LTR circles. 
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